Not for use with other long-acting β 2-agonists. Do not exceed recommended dose. Prescribe a short-acting, inhaled β 2-agonist for acute symptoms; monitor for increased need. Monitor for signs ...

Developed with US respiratory specialist firm Innoviva, the drug (known as Breo Ellipta in the US ... in a single inhaler, the Ellipta. Sales of the drug are starting to pick up since its ...

Efforts to supplant pressurised metered-dose inhalers (pMDIs) with DPIs, most recently by the European Network on ... Meanwhile GSK's lead inhalers include Trelegy Ellipta, projected to bring $3.3bn ...

The FDA has approved an expanded label for GlaxoSmithKline’s new Trelegy Ellipta inhaler, allowing it to ... provide a more convenient single daily dose for patients with advanced disease ...